GAIA BioMedicine Inc., a spin-out venture from Kyushu University founded on 2015, is a technology-driven biopharmaceutical company focusing on cellular therapies and immunotherapies mainly for intractable malignancies.
Investors 1
| Date | Name | Website |
| - | QB Capital... | qbc.co.jp |